The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease:: Phenotype in monozygotic twins

被引:18
|
作者
Munhoz, Renato P. [1 ]
Wakutani, Yosuke [2 ]
Marras, Connie [3 ]
Teive, Helio A. [1 ]
Raskin, Salmo [4 ]
Werneck, Lineu C. [1 ]
Moreno, Danielle [2 ]
Sato, Christine [2 ]
Lang, Anthony E. [3 ,5 ]
Rogaeva, Ekaterina [2 ,5 ]
机构
[1] Univ Fed Parana, Hosp Clin, Neurol Serv, Movement Disorders Unit, Curitiba, Parana, Brazil
[2] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[3] Univ Toronto, Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON, Canada
[4] Genet Lab, Curitiba, Parana, Brazil
[5] Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
mutation; Parkinson's disease; G2919S; LRRK; Brazil;
D O I
10.1002/mds.21832
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the Leucine-Rich Repeat Kinase 2 gene (LRRK2) are mainly responsible for idiopathic Parkinson's disease (PD) with either a dominant pattern of transmission or a sporadic occurrence due to the reduced penetrance. A majority of LRRK2 kindreds demonstrate an extremely variable age-at-onset in affected members of the same family. The G2019S is the most common LRRK2 mutation, which accounts for 1-5% PD patients in North America, and up to 40% of patients from an isolated Arab population. We assessed the frequency of the G2019S mutation in 83 Brazilian PD patients originally preselected for having an early age-at-onset (< 50 years) and/or a positive family history. The mutation was detected in three probands (3.5%). Our clinical findings in these kindreds include the first description of the phenotype in identical twins discordant for handedness (a general phenomenon found in similar to 25% monozygotic twins). However, both twins developed right asymmetric PD. The clinical presentation of twins was strikingly similar including an identical PD onset at age 60. This observation may suggest that genetic factors predominantly determine age-at-onset. (C) 2007 Movement Disorder Society.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 50 条
  • [31] High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain)
    Sierra, Maria
    Gonzalez-Aramburu, Isabel
    Sanchez-Juan, Pascual
    Sanchez-Quintana, Coro
    Miguel Polo, Jose
    Berciano, Jose
    Combarros, Onofre
    Infante, Jon
    MOVEMENT DISORDERS, 2011, 26 (13) : 2343 - 2346
  • [32] Dyskinesias in patients with Parkinson's disease: Effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation
    Yahalom, Gilad
    Kaplan, Natalie
    Vituri, Aya
    Cohen, Oren S.
    Inzelberg, Rivka
    Kozlova, Evgenia
    Korczyn, Amos D.
    Rosset, Saharon
    Friedman, Eitan
    Hassin-Baer, Sharon
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (09) : 1039 - 1041
  • [33] Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease
    Iovino, L.
    Vanderzwaag, J.
    Kaur, G.
    Khakpour, M.
    Giusti, V.
    Donadon, M.
    Chiavegato, A.
    Tenorio-Lopes, L.
    Greggio, E.
    Tremblay, M. E.
    Civiero, L.
    NEUROBIOLOGY OF DISEASE, 2024, 195
  • [34] LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study
    Sharma, S.
    Bandopadhyay, R.
    Lashley, T.
    Renton, A. E. M.
    Kingsbury, A. E.
    Kumaran, R.
    Kallis, C.
    Vilarino-Gueell, C.
    O'Sullivan, S. S.
    Lees, A. J.
    Revesz, T.
    Wood, N. W.
    Holton, J. L.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2011, 37 (07) : 777 - 790
  • [35] The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's disease
    Moeller, J. C.
    Rissling, I.
    Mylius, V.
    Hoeft, C.
    Eggert, K. M.
    Oertel, W. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (07) : 743 - 745
  • [36] Gait Alterations in Healthy Carriers of the LRRK2 G2019S Mutation
    Mirelman, Anat
    Gurevich, Tanya
    Giladi, Nir
    Bar-Shira, Anat
    Orr-Urtreger, Avi
    Hausdorff, Jeffrey M.
    ANNALS OF NEUROLOGY, 2011, 69 (01) : 193 - 197
  • [37] LRRK2 G2019S Mutations are Associated with an Increased Cancer Risk in Parkinson Disease
    Saunders-Pullman, Rachel
    Barrett, Matthew J.
    Stanley, Kaili M.
    San Luciano, Marta
    Shanker, Vicki
    Severt, Lawrence
    Hunt, Ann
    Raymond, Deborah
    Ozelius, Laurie J.
    Bressman, Susan B.
    MOVEMENT DISORDERS, 2010, 25 (15) : 2536 - 2541
  • [38] Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients
    Felipe Duque, Andres
    Carlos Lopez, Juan
    Benitez, Bruno
    Hernandez, Helena
    Jose Yunis, Juan
    Fernandez, William
    Arboleda, Humberto
    Arboleda, Gonzalo
    COLOMBIA MEDICA, 2015, 46 (03): : 117 - 121
  • [39] Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant
    Kmiecik, Matthew J.
    Micheletti, Steven
    Coker, Daniella
    Heilbron, Karl
    Shi, Jingchunzi
    Stagaman, Keaton
    Sonmez, Teresa Filshtein
    Fontanillas, Pierre
    Shringarpure, Suyash
    Wetzel, Madeleine
    Rowbotham, Helen M.
    Cannon, Paul
    Shelton, Janie F.
    Hinds, David A.
    Tung, Joyce Y.
    Holmes, Michael, V
    Aslibekyan, Stella
    Norcliffe-Kaufmann, Lucy
    BRAIN, 2024, 147 (06) : 1996 - 2008
  • [40] Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene
    Li, Xiao-Xia
    Liao, Qin
    Xia, Huan
    Yang, Xin-Ling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (04) : 1450 - 1454